UK researchers recruited 757 patients with type 1 diabetes duration of at least 3 years and found that 13 of 14 of those whose C-peptide levels greater than 900 pmol/L were reclassified as having type 2 diabetes, while other patients at varying C-peptide levels were reclassified as having different genetic types of diabetes. The findings, presented at the Diabetes UK Professional Conference, also showed that some patients with diabetic ketoacidosis actually had type 2 diabetes.
Study: C-peptide testing important after diabetes diagnosis
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.